Hypoxic pulmonary endothelial cells release epidermal growth factor leading to vascular smooth muscle cell arginase‐2 expression and proliferation
Abstract The hallmark of pulmonary hypertension (PH) is vascular remodeling. We have previously shown that human pulmonary microvascular endothelial cells (hPMVEC) respond to hypoxia with epidermal growth factor (EGF) mediated activation of the receptor tyrosine kinase, EGF receptor (EGFR), resultin...
Main Authors: | Bernadette Chen, Yi Jin, Caitlyn M. Pool, Yusen Liu, Leif D. Nelin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | Physiological Reports |
Subjects: | |
Online Access: | https://doi.org/10.14814/phy2.15342 |
Similar Items
-
Nitric oxide activates AMPK by modulating PDE3A in human pulmonary artery smooth muscle cells
by: Julie Dillard, et al.
Published: (2020-09-01) -
Impact of l‐citrulline on nitric oxide signaling and arginase activity in hypoxic human pulmonary artery endothelial cells
by: Matthew S. Douglass, et al.
Published: (2023-04-01) -
circ-BPTF serves as a miR-486-5p sponge to regulate CEMIP and promotes hypoxic pulmonary arterial smooth muscle cell proliferation in COPD
by: Wang Changguo, et al.
Published: (2022-12-01) -
Traditional Chinese medicine monomers: Targeting pulmonary artery smooth muscle cells proliferation to treat pulmonary hypertension
by: Xiuli Yang, et al.
Published: (2023-04-01) -
Arginase impairs hypoxic pulmonary vasoconstriction in murine endotoxemia
by: Bodil Petersen, et al.
Published: (2019-06-01)